Low level of basal testosterone: a significant risk factor for poor oocyte yield after ovulation induction
Jing Guo A , Qingxue Zhang A , Yu Li A , Wenjun Wang A and Dongzi Yang A B
+ Author Affiliations
- Author Affiliations
A Department of Obstetrics and Gynaecology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang Road, Guangzhou 510120, Guangdong, China.
B Corresponding author. Email: yangdz@mail.sysu.edu.cn
Reproduction, Fertility and Development 28(3) 286-292 https://doi.org/10.1071/RD14061
Submitted: 16 February 2014 Accepted: 23 May 2014 Published: 15 July 2014
Abstract
The objective of this study was to further investigate the association of low androgen levels and poor ovarian response or negative pregnancy outcome in in vitro fertilisation treatment using a retrospective cohort study. Chinese women (n = 1950) of relatively young age, with normal range of basal FSH and antral follicle count undergoing an in vitro fertilisation cycle were selected and testosterone and dehydroepiandrosterone sulfate levels were measured on Day 3 of the menstrual cycle before subsequent in vitro fertilisation treatment. The main outcome measures of the study were ovarian stimulation parameters and clinical pregnancy. Basal testosterone levels of poor responders and non-pregnant women were significantly lower than normal responders and pregnant women, respectively. Patients with low basal testosterone levels had significantly lower number of mature oocytes, cleavage-stage embryos, frozen embryos, lower fertilisation and pregnancy rates and required higher doses of gonadotrophins. Androgen levels had no correlation with early spontaneous abortion rates. Multivariable logistic analysis revealed that low basal testosterone (<0.88 nmol L–1) was an independent risk factor for poor oocyte yield (odds ratio: 1.61; 95% confidence interval: 1.01–2.57; P = 0.045). In conclusion, a low level of basal testosterone was a significant risk factor for poor oocyte yield after ovarian stimulation and might negatively influence pregnancy chances with in vitro fertilisation. Basal dehydroepiandrosterone sulfate levels were not predictive for poor ovarian response or negative pregnancy outcome in this population.
Additional keywords: dehydroepiandrosterone sulphate, in vitro fertilisation, poor ovarian response.
References
Barad, D., and Gleicher, N. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum. Reprod. 21, 2845–2849.| Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28XhtVynsr%2FE&md5=265a29bae4f67cdb1fedd8d9d0c93759CAS | 16997936PubMed |
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., and Lambalk, C. B. (2006). A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 12, 685–718.
| A systematic review of tests predicting ovarian reserve and IVF outcome.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD28nhtlCquw%3D%3D&md5=57047bc33d179e60feaf7493cefdfb06CAS | 16891297PubMed |
Bukman, A., and Heineman, M. J. (2001). Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum. Reprod. Update 7, 581–590.
| Ovarian reserve testing and the use of prognostic models in patients with subfertility.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MnotFKiuw%3D%3D&md5=c1567d9367884e7dec758eb514a629feCAS | 11727867PubMed |
Colakoglu, M. (1986). The effect of dehydroepiandrosterone sulfate prolactin and testosterone hormones in female fertility and hirsutism. Clin. Exp. Obstet. Gynecol. 13, 32–34.
| 1:STN:280:DyaL283hvVGnsQ%3D%3D&md5=0af0d1dc4961d6f7bbf90adfe5875345CAS | 2940031PubMed |
De Vos, M., Devroey, P., and Fauser, B. C. (2010). Primary ovarian insufficiency. Lancet 376, 911–921.
| Primary ovarian insufficiency.Crossref | GoogleScholarGoogle Scholar | 20708256PubMed |
Figueira, R. C., Braga, D. P., Nichi, M., Madaschi, C., Semiao-Francisco, L., Iaconelli, A., and Borges, E. (2009). Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function? Hum. Fertil. (Camb.) 12, 160–165.
| Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function?Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhtlOktrvO&md5=85d92288590c2dd10af067a35470c6b8CAS |
Frattarelli, J. L., and Gerber, M. D. (2006). Basal and cycle androgen levels correlate with in vitro fertilisation stimulation parameters but do not predict pregnancy outcome. Fertil. Steril. 86, 51–57.
| Basal and cycle androgen levels correlate with in vitro fertilisation stimulation parameters but do not predict pregnancy outcome.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28XotV2jsrk%3D&md5=84c1198f1f12d2d1c21aaa97a53f4f19CAS | 16716312PubMed |
Frattarelli, J. L., and Peterson, E. H. (2004). Effect of androgen levels on in vitro fertilisation cycles. Fertil. Steril. 81, 1713–1714.
| Effect of androgen levels on in vitro fertilisation cycles.Crossref | GoogleScholarGoogle Scholar | 15193506PubMed |
Gleicher, N., and Barad, D. H. (2011). Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod. Biol. Endocrinol. 9, 67.
| Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXms1SqtL8%3D&md5=ff8ed8d8173bcb6c071b685428797038CAS | 21586137PubMed |
Guo, J., Zhang, Q., Li, Y., Huang, J., Wang, W., Huang, L., Zhao, X., and Yang, D. (2014). Predictive value of androgens and multivariate model for poor ovarian response. Reprod. Biomed. Online 28, 723–732.
| Predictive value of androgens and multivariate model for poor ovarian response.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXmtlSktL8%3D&md5=e257705703288bd093c1951988b7a067CAS | 24745840PubMed |
Haning, R. V., Hackett, R. J., Flood, C. A., Loughlin, J. S., Zhao, Q. Y., and Longcope, C. (1993). Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J. Clin. Endocrinol. Metab. 76, 1301–1307.
| 1:CAS:528:DyaK3sXkvVKmtr8%3D&md5=3dd0c672eed01487e027f0ec7fff6ae2CAS | 8496321PubMed |
Hossein Rashidi, B., Hormoz, B., Shahrokh, T. E., Shariat, M., and Mahdavi, A. (2009). Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results. Gynecol. Endocrinol. 25, 194–198.
| Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results.Crossref | GoogleScholarGoogle Scholar | 19347710PubMed |
Jayaprakasan, K., Al-Hasie, H., Jayaprakasan, R., Campbell, B., Hopkisson, J., Johnson, I., and Raine-Fenning, N. (2009). The three-dimensional ultrasonographic ovarian vascularity of women developing poor ovarian response during assisted reproduction treatment and its predictive value. Fertil. Steril. 92, 1862–1869.
| The three-dimensional ultrasonographic ovarian vascularity of women developing poor ovarian response during assisted reproduction treatment and its predictive value.Crossref | GoogleScholarGoogle Scholar | 18973895PubMed |
Kim, C. H., Howles, C. M., and Lee, H. A. (2011). The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil. Steril. 95, 679–683.
| The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXpsl2jtg%3D%3D&md5=658836a9c298b52b8c93037c32261a6bCAS | 20801436PubMed |
Lenie, S., and Smitz, J. (2009). Functional AR signalling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol. Reprod. 80, 685–695.
| Functional AR signalling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXjvVSktb8%3D&md5=f0ad70ead4f3cf01c181f0249643114fCAS | 19074005PubMed |
Li, Y., Yang, D., and Zhang, Q. (2010). Impact of overweight and underweight on IVF treatment in Chinese women. Gynecol. Endocrinol. 26, 416–422.
| Impact of overweight and underweight on IVF treatment in Chinese women.Crossref | GoogleScholarGoogle Scholar | 20170351PubMed |
Mitwally, M. F., and Casper, R. F. (2002). Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil. Steril. 77, 776–780.
| Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders.Crossref | GoogleScholarGoogle Scholar | 11937133PubMed |
Mukherjee, T., Copperman, A. B., Lapinski, R., Sandler, B., Bustillo, M., and Grunfeld, L. (1996). An elevated day three follicle-stimulating hormone:luteinising hormone ratio (FSH:LH) in the presence of a normal Day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil. Steril. 65, 588–593.
| 1:STN:280:DyaK28zntVeqtA%3D%3D&md5=a95a8380777fdd340e668aa3ed851cceCAS | 8774292PubMed |
Mutlu, M. F., Erdem, M., Erdem, A., Yildiz, S., Mutlu, I., Arisoy, O., and Oktem, M. (2013). Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilisation cycles. J. Assist. Reprod. Genet. 30, 657–665.
| Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilisation cycles.Crossref | GoogleScholarGoogle Scholar | 23508679PubMed |
Orentreich, N., Brind, J. L., Rizer, R. L., and Vogelman, J. H. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59, 551–555.
| Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL2cXlsVCns7g%3D&md5=9b13955ac53509b524f7956d31e12f4aCAS | 6235241PubMed |
Pu, D., Wu, J., and Liu, J. (2011). Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum. Reprod. 26, 2742–2749.
| Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXht1SiurzI&md5=9a758f6bbd1a72697e98d058dac978e4CAS | 21778283PubMed |
Qin, Y., Zhao, Z., Sun, M., Geng, L., Che, L., and Chen, Z. J. (2011). Association of basal serum testosterone levels with ovarian response and in vitro fertilisation outcome. Reprod. Biol. Endocrinol. 9, 9.
| Association of basal serum testosterone levels with ovarian response and in vitro fertilisation outcome.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXht1Ohtr4%3D&md5=0a6debc0d470a3a1138b3454cc559757CAS | 21247501PubMed |
Scott, R. T., Toner, J. P., Muasher, S. J., Oehninger, S., Robinson, S., and Rosenwaks, Z. (1989). Follicle-stimulating hormone levels on cycle Day 3 are predictive of in vitro fertilisation outcome. Fertil. Steril. 51, 651–654.
| 1:STN:280:DyaL1M7ntFersg%3D%3D&md5=94eae4565cec35ddaa05a3b204c137aeCAS | 2494082PubMed |
Scott, R. T., Hofmann, G. E., Oehninger, S., and Muasher, S. J. (1990). Intercycle variability of Day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilisation. Fertil. Steril. 54, 297–302.
| 2116330PubMed |
Seifer, D. B., Lambert-Messerlian, G., Hogan, J. W., Gardiner, A. C., Blazar, A. S., and Berk, C. A. (1997). Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 67, 110–114.
| Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s7ktVaisw%3D%3D&md5=d69671b1b7a848d159b097555e731cb9CAS | 8986693PubMed |
Steckler, T., Wang, J., Bartol, F. F., Roy, S. K., and Padmanabhan, V. (2005). Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology 146, 3185–3193.
| Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2MXlslGht78%3D&md5=06a01cb48a49b7d26406b65d349adbf9CAS | 15802500PubMed |
Surrey, E. S., and Schoolcraft, W. B. (2000). Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil. Steril. 73, 667–676.
| Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c7pvVSqsg%3D%3D&md5=6728df7028150b28834c2a0857506442CAS | 10731523PubMed |
The Rotterdam ESHRE/ASRM‐sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41–47.
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Crossref | GoogleScholarGoogle Scholar | 14688154PubMed |
Vendola, K., Zhou, J., Wang, J., and Bondy, C. A. (1999). Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum. Reprod. 14, 2328–2332.
| Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK1MXms1yqsL4%3D&md5=6bd70ba1cb9cb459948cb6266d38b6acCAS | 10469704PubMed |
Weghofer, A., Kim, A., Barad, D. H., and Gleicher, N. (2012). The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum. Reprod. 27, 3287–3293.
| The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhsFKmu7rK&md5=9c337cd2d046ec77d6cecf8a171d4fdcCAS | 22811313PubMed |
Weil, S., Vendola, K., Zhou, J., and Bondy, C. A. (1999). Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab. 84, 2951–2956.
| Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK1MXltFCltbk%3D&md5=11996f58f0cf3cd49b680e3b12b656f5CAS | 10443703PubMed |
Wiser, A., Gonen, O., Ghetler, Y., Shavit, T., Berkovitz, A., and Shulman, A. (2010). Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomised prospective study. Hum. Reprod. 25, 2496–2500.
| Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomised prospective study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtFyltLjE&md5=92e1578374617f6e09adc3a1a37553ffCAS | 20729538PubMed |
Younis, JS (2012). The Bologna criteria for poor ovarian response; has the job been accomplished? Hum. Reprod. 27, 1874–1875.
| The Bologna criteria for poor ovarian response; has the job been accomplished?Crossref | GoogleScholarGoogle Scholar | 22473398PubMed |
Zhao, X., He, Z., Mo, Y., Chen, X., Chen, Y., and Yang, D. (2011). Determining the normal cut-off levels for hyperandrogenaemia in Chinese women of reproductive age. Eur. J. Obstet. Gynecol. Reprod. Biol. 154, 187–191.
| Determining the normal cut-off levels for hyperandrogenaemia in Chinese women of reproductive age.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhvV2ntLg%3D&md5=25e615a06815fa41d7e9078f0617ea11CAS | 21111526PubMed |
